Brief: Interpace Biosciences - H.C. Wainwright Cuts Price Target To $10 From $11
Oct 22 (Reuters) - Interpace Biosciences Inc IDXG.O :
* : H.C. WAINWRIGHT CUTS PRICE TARGET TO $10 FROM $11
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million